Voglow 0.3 GM 2 Tablet SR
Marketer
Primus Remedies Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Voglow 0.3 GM 2 Tablet SR
Diabetic patients (adults) can manage type 2 diabetes mellitus with the anti-diabetic medication, Voglow 0.3 GM 2 Tablet SR. This dual-action formulation helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as cessation without medical supervision risks elevated glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, Voglow 0.3 GM 2 Tablet SR complements a comprehensive diabetes management plan including diet, exercise, and weight control as directed by your doctor. Lifestyle modifications are vital. Hypoglycemia (low blood sugar) is a frequent side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with a readily available fast-acting glucose source (sugary foods or juice). Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should consult their physician before commencing treatment. Pregnant or lactating women should seek medical advice. Regular blood sugar checks are essential, alongside potential blood tests to monitor blood cell counts and liver health.
Uses of Voglow 0.3 GM 2 Tablet SR
Managing type 2 diabetes
Major Benefits of Voglow 0.3 GM 2 Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Voglow 0.3 GM 2 Tablet SR should be administered on an empty stomach.
Common Side effects of Voglow 0.3 GM 2 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglow 0.3 GM 2 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablets whole; avoid chewing, crushing, or fracturing them. Administer Voglow 0.3 GM 2 Tablet SR on an empty stomach.
How Voglow 0.3 GM 2 Tablet SR works:
Voglow SR tablets (0.3g, 2 count) contain a triple-action antidiabetic formula.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglow 0.3 GM 2 Tablet SR and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Pregnant individuals may experience adverse effects from Voglow 0.3 GM 2 Tablet SR. While human data is scarce, animal research indicates potential harm to the fetus. Prescribing decisions will consider the relative benefits and risks. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Voglow 0.3-gram, two-tablet dosage form is likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Employing Voglow 0.3 GM 2 Tablet SR carries a high risk for individuals with kidney impairment and is best avoided. Medical advice is recommended. Furthermore, this medication is unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver disease should use Voglow 0.3 GM 2 Tablet SR cautiously, potentially requiring dose modification. Consult a physician. A low initial dose of Voglow 0.3 GM 2 Tablet SR is typically prescribed for those with mild to moderate liver impairment; however, its use is contraindicated in patients with severe liver disease.
What if you forget to take Voglow 0.3 GM 2 Tablet SR :
Should you forget to take a Voglow 0.3 GM 2 Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Voglow 0.3 GM 2 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


